Greenwich LifeSciences (GLSI) Intangibles (2019 - 2025)

Greenwich LifeSciences (GLSI) has 7 years of Intangibles data on file, last reported at $876.0 in Q1 2025.

• Quarterly Intangibles fell 80.48% year-over-year to $876.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $876.0 (down 80.48% YoY) and the FY2024 annual result came in at $1779.0, down 67.0% from the prior year.
• Intangibles slipped to $876.0 in Q1 2025, from $1779.0 in the prior quarter.
• In the past five years, Intangibles ranged from a high of $15324.0 in Q1 2021 to a low of $876.0 in Q1 2025.
• A 5-year average of $8100.0 and a median of $8100.0 in 2023 frame the typical range for Intangibles.
• Annual changes were most pronounced in 2021 — Intangibles declined 21.09% — and 2025, when it plunged 80.48%.
• Tracing GLSI's Intangibles over 5 years: stood at $12615.0 in 2021, then retreated by 28.63% to $9003.0 in 2022, then tumbled by 40.12% to $5391.0 in 2023, then slumped by 67.0% to $1779.0 in 2024, then sank by 50.76% to $876.0 in 2025.
• The last three Intangibles figures came in at $876.0 (Q1 2025), $1779.0 (Q4 2024), and $2682.0 (Q3 2024), per Business Quant data.